Guro Elisabeth Lind

10PUBLICATIONS
7CO-AUTHORS
Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Cancer diagnosisCancer geneticsGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Dec 08, 2025
Molecular stratification of esophageal adenocarcinoma: implications for prognosis and treatment strategy.

Rita Pinto, Ingrid Vikan Sjurgard, Heidi Pharo

|Nov 20, 2025
From concept to clinic: a roadmap for DNA methylation biomarkers in liquid biopsies.

Heidi Pharo, Hege Marie Vedeld, Ingrid Vikan Sjurgard

|Dec 19, 2024
Unraveling epigenetic heterogeneity across gastrointestinal adenocarcinomas through a standardized analytical framework.

Rita Pinto, Hege Marie Vedeld, Guro Elisabeth Lind

|May 09, 2024
Distinct longitudinal patterns of urine tumor DNA in patients undergoing surveillance for bladder cancer.

Hege Marie Vedeld, Heidi Pharo, Anne Klara Sørbø

|Jun 14, 2022
Targeted genetic and epigenetic profiling of esophageal adenocarcinomas and non-dysplastic Barrett's esophagus.

Rita Pinto, Tobias Hauge, Marine Jeanmougin

|Dec 07, 2020
Multiregional assessment of CIMP in primary colorectal cancers: Phenotype concordance but marker variability.

Bjørnar T B Flatin, Hege Marie Vedeld, Rita Pinto

Pageof 2

Frequent Collaborators

3 joint publications

Rita Pinto

3 joint publications

Heidi Pharo

2 joint publications

Ingrid Vikan Sjurgard

1 joint publications

Bjørnar T B Flatin